Zacks Investment Research on MSN
All you need to know about Cognizant (CTSH) rating upgrade to buy
Cognizant (CTSH) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices ...
The Fiserv (FI) crash last week came as a surprise to some, but it wasn't a shocker for investors who pay attention to Seeking Alpha Quant Ratings. While SA Analysts and Wall Street had FI as a Buy, ...
Zacks.com on MSN
TEMENOS GROUP (TMSNY) Upgraded to Buy: Here's Why
TEMENOS GROUP (TMSNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Neurocrine Biosciences (NBIX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...
Investors might want to bet on Axcelis Technologies (ACLS), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...
Director Edward Basile's transaction at TransMedics represents a routine "cashless exercise," which is a common move where ...
IonQ (IONQ) has been one of the market’s most closely watched quantum computing names — a company at the frontier of a transformative technology, but also one still searching for consistent ...
Nvidia stock has surged 1,400% over the last three years. While shares have gained significantly, the company still has several catalysts on the horizon. Accelerating AI infrastructure combined with ...
Veeva Systems is rated a buy, with strong revenue and EPS growth, raised FY2026 guidance, and a misunderstood sell-off creating a long-term opportunity. VEEV's migration to Vault CRM is progressing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results